In addition, in AML children, KAI1/CD82 mRNA expression increases the expression of downstream molecules in the Wnt/β-catenin pathway such as β-catenin, c-myc, cyclinD1, and survivin. The gene discussed is CD82; the disease is acute myeloid leukemia.